BURLINGTON, Mass., Aug. 16, 2012 (GLOBE NEWSWIRE) -- Coronado Biosciences, Inc. (Nasdaq:CNDO), a biopharmaceutical company focused on the development of novel immunotherapy biologic agents for the treatment of autoimmune diseases and cancer, announced today that Harlan F. Weisman, M.D., was elected to its board of directors at its Annual Meeting of Stockholders. Dr. Weisman brings over 20 years of experience as a senior healthcare executive and physician responsible for the development, regulatory approval and launch of innovative biopharmaceutical, medical device and diagnostic products. Dr. Weisman is the former Chief Science and Technology Officer for the Johnson & Johnson (J&J) Medical Devices and Diagnostics Group as well as former Company Group Chairman, Research & Development for Pharmaceuticals at J&J.
Dr. Harlan Weisman Elected To Board Of Directors Of Coronado Biosciences
Check Out Our Best Services for Investors
Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts
David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
Every recommendation goes through 3 layers of intense scrutinyquantitative, fundamental and technical analysisto maximize profit potential and minimize risk.
Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.